42C SES Week ended 31 Jul 2026

Weekly Investor Report

Name: 42C weekly investor report
Creator: Sharemaestro
License: https://sharemaestro.com/data-license/

iX Biopharma Ltd. · Healthcare · Drug Manufacturers - Specialty & Generic

Open interactive chart View report data

Latest close 0.51 SGD

24.7% latest week

Weekly setup

Constructive, but selective

The weekly trend is active. Price is 66.9% above the Trend Line and sits at 91.5% of its 52-week range. The latest completed week returned 24.7%, after a 34.7% four-week move. The latest news-sentiment score is 48/100. Near-term considerations: price is close to its 52-week high.

Setup score 74 out of 100

Latest Close 0.51 SGD 31 Jul 2026

1W Return 24.7% latest completed week

4W Return 34.7% short-term follow-through

12W Return 23.2% quarterly tape

Trend Breadth 86.5% 45 of 52 weeks active

Volume Ratio 3.6x vs 13-week average

What is working

The trend backdrop is active with a 45-week active streak.
Price is above the Trend Line, keeping the weekly tape constructive.
Price is above Fair Value, showing premium demand versus the model.
Volume is elevated versus the 13-week average, confirming attention.

What could go wrong

Activity pressure is negative, which weakens the current setup.
3 reversal markers appear in the recent smart-money tape.

What to watch next

Trend Line remains the key weekly regime level.
Activity pressure is the gauge to monitor for confirmation or fade.
A volume ratio above 1.5x would show stronger participation in the next move.

Price follow-through 24.7% Latest completed week; four-week move 34.7%. Indicator stack 93/44 Trend and activity pressure are weighted against the latest 12-week confirmation window. Trend backdrop Active The trend backdrop defines the current weekly regime. Patient Capital Quiet Activity-pressure buy-signal status for institutional accumulation timing. News sentiment 48/100 21 relevant articles in the latest sentiment read.

01 · Price action

Where price is—and whether the trend supports it

The weekly trend is active. Price is 66.9% above the Trend Line and sits at 91.5% of its 52-week range. The latest completed week returned 24.7%, after a 34.7% four-week move.

Study the full chart

52-week price path

Price vs Trend Line and Fair Value

Price Trend Line Fair Value

Position in the 52-week range

Close Trend Fair

0.02 SGD 91.5% 0.55 SGD

Range location91.5%Shows where the latest close sits between the 52-week low and high.

Trend distance66.9%Price premium or discount versus the weekly Trend Line.

Fair-value gap457.2%Premium demand or model discount versus Sharemaestro Fair Value.

High-water gap-8.2%Distance from the latest 52-week high.

02 · Volume and demand

Is real participation confirming the move?

Latest weekly volume is 3.6x the 13-week average. Participation is unusually strong and confirms that the move is attracting attention.

26-week volume confirmation

Bar height shows volume; colour shows the weekly price direction

6 Feb 13 Feb 20 Feb 27 Feb 6 Mar 13 Mar 20 Mar 27 Mar 3 Apr 10 Apr 17 Apr 24 Apr 1 May 8 May 15 May 22 May 29 May 5 Jun 12 Jun 19 Jun 26 Jun 3 Jul 10 Jul 17 Jul 24 Jul 31 Jul

Up week Down week

Demand beneath price

Activity pressure and institutional-style signals

These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.

Activity pressure path

Latest 0.8012-week average 0.89

12-week confirmation

Trend active12/12Active trend-backdrop weeks in the latest 12-week window.

Positive pressure6/12Weeks with constructive activity pressure in the latest 12-week window.

Positive leadership12/12Weeks with positive relative leadership in the latest 12-week window.

Activity pressure0.80Current proprietary activity-pressure read.

Buy signals0Accumulation signal count in the latest 12 weeks.

Reversal markers33 reversal markers

No recent accumulation markers. 3 reversal markers.

03 · Momentum and leadership

Is performance persistent—and is the stock leading?

Performance is 34.7% over four weeks, 23.2% over 12 weeks, and 2557.9% over one year. The current trend has remained active for 45 consecutive weeks.

Performance by holding period

1W24.7%

4W34.7%

12W23.2%

26W174.5%

52W2557.9%

Active trend streak45 weeks

Active weeks in one year45

Trend breadth86.5%

Activity pressure vs relative leadership

Activity pressureRelative leadership

Pressure-0.26Latest activity-pressure read.

Pressure change-22.0%Four-week change in activity pressure.

Leadership114.84Latest relative-leadership reading.

RS change18.8%Four-week change in relative leadership.

04 · Fundamentals and valuation

What investors are paying for—and the quality behind it

A published fundamentals and factor snapshot is not available for this company.

Open full factor analysis

No published fundamental snapshot is available for this company.

05 · Ownership, options, and sentiment

What other market participants are doing

Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.

Insider activity-

No recent insider transactions are stored for this company.

News sentiment48/100

Weighted news tone is neutral across 21 relevant articles.

3 positive · 14 neutral · 4 negative

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal

06 · Catalysts and risk

What can move the shares—and how volatile the path has been

Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.

Next earnings-No event is currently stored.

Options expected move-Nearest-chain priced movement where available.

52-week drawdown-8.2%Distance below the 52-week high.

13-week volatility9.6%Standard deviation of weekly returns.

Weekly gains and losses

Latest 26 completed weeks

Each bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.

6 Feb 6 Mar 3 Apr 1 May 29 May 26 Jun 31 Jul

Weeks higher13 of 269 weeks finished lower.

Best week+67.5%Week of 10 Apr.

Worst week-10.1%Week of 26 Jun.

Latest week+24.7%Week of 31 Jul.

Shape of recent returns

Strong gains11

Modest gains2

Flat weeks4

Modest losses1

Sharp losses8

Recent vol9.6%13-week weekly-return volatility.

Base vol25.8%52-week weekly-return volatility.

Up/down split27/20Count of positive and negative weeks in the 52-week window.

Average skew20.2% / -4.9%Average positive week versus average negative week.

07 · Sector and peer context

Is this stock leading—or simply moving with its group?

Sector and industry breadth distinguish company-specific strength from a broad group move.

SectorSG Healthcare

4-week rank1 / 35

Group average-3.4%

Trend breadth31.4%

Trend31.4%active weekly trend signals

MD28.6%positive activity pressure

RS20.0%positive relative leadership

Four-week leaders

42C · SES34.7%584 · SES25.0%GRQ · SES17.8%5RE · SES6.7%569 · SES4.1%

IndustrySG Drug Manufacturers - Specialty & Generic

4-week rank1 / 4

Group average-10.9%

Trend breadth25.0%

Trend25.0%active weekly trend signals

MD25.0%positive activity pressure

RS25.0%positive relative leadership

Four-week leaders

42C · SES34.7%8A8 · SES1.0%T14 · SES0.7%BFK · SES-80.0%

08 · Evidence and weekly data

The underlying research record

Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.

Weekly tape71/100

Trend, activity pressure, participation, and risk combine to a 71/100 tape read.

Indicator analysis71/100

Latest 12-week confirmation: trend 12/12, activity pressure 6/12, relative leadership 12/12.

Activity pressure 0.80; 3 reversal markers Factors50/100

No published factor snapshot is available yet.

Patient CapitalQuiet

Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.

No recent buy signal Sentiment48/100

Weighted news tone is neutral across 21 relevant articles.

iX Biopharma Ltd. Revenue Breakdown – SGX:42C Insiders50/100

No recent insider transaction evidence is stored.

Earnings50/100

No stored earnings event is currently attached to this ticker.

Week	Close	Return	Trend Line	Fair Value	Pressure	Leadership	Volume	Trend
31 Jul 2026	0.51 SGD	24.7%	0.30 SGD	0.09 SGD	-0.26	114.84	180.9M	On
24 Jul 2026	0.41 SGD	8.0%	0.29 SGD	0.09 SGD	-0.52	80.62	54.1M	On
17 Jul 2026	0.38 SGD	0.0%	0.28 SGD	0.09 SGD	-0.55	75.33	34.7M	On
10 Jul 2026	0.38 SGD	0.0%	0.27 SGD	0.08 SGD	-0.34	82.36	36.9M	On
3 Jul 2026	0.38 SGD	5.6%	0.26 SGD	0.08 SGD	-0.21	96.64	34.9M	On
26 Jun 2026	0.35 SGD	-10.1%	0.26 SGD	0.08 SGD	-0.12	94.97	7.0M	On
19 Jun 2026	0.40 SGD	8.2%	0.25 SGD	0.08 SGD	0.15	124.83	10.8M	On
12 Jun 2026	0.36 SGD	2.8%	0.24 SGD	0.08 SGD	0.19	123.77	11.6M	On
5 Jun 2026	0.35 SGD	-7.8%	0.23 SGD	0.07 SGD	0.39	125.73	7.9M	On
29 May 2026	0.39 SGD	11.6%	0.22 SGD	0.07 SGD	0.74	155.82	45.5M	On
22 May 2026	0.34 SGD	-6.8%	0.21 SGD	0.07 SGD	0.90	138.87	41.4M	On
15 May 2026	0.37 SGD	-9.8%	0.21 SGD	0.07 SGD	1.16	171.93	68.3M	On
8 May 2026	0.41 SGD	7.9%	0.20 SGD	0.07 SGD	1.37	221.25	120.5M	On
1 May 2026	0.38 SGD	0.0%	0.19 SGD	0.07 SGD	1.30	216.65	60.7M	On

How to use this report

This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.